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Experimental challengeScrapie is the transmissible spongiform encephalopathy (TSE) of sheep and goats, and scrapie eradication in
sheep is based in part on strong genetic resistance to classical scrapie. Goats may serve as a scrapie reservoir,
and to date there has been no experimental inoculation conﬁrming strong genetic resistance in goats.
Two prion protein variants (amino acid substitutions S146 and K222) in goats have been signiﬁcantly
underrepresented in scrapie cases though present in scrapie-exposed ﬂocks, and have demonstrated low cell-
free protein conversion efﬁciency to the disease form (PrPD). To test degree of genetic resistance conferred in
live animals with consistent exposure, we performed the ﬁrst oral scrapie challenge of goats singly
heterozygous for either PRNP S146 or K222. All N146-Q222 homozygotes became clinically scrapie positive
by an average of 24 months, but all S146 and K222 heterozygotes remain scrapie negative by both rectal
biopsy and clinical signs at signiﬁcantly longer incubation times (Pb0.0001 for both comparisons). Recent
reports indicate small numbers of S146 and K222 heterozygous goats have become naturally infected with
scrapie, suggesting these alleles do not confer complete resistance in the heterozygous state but rather
extend incubation. The oral challenge results presented here conﬁrm extended incubation observed in a
recent intracerebral challenge of K222 heterozygotes, and to our knowledge provide the ﬁrst demonstration
of extended incubation in S146 heterozygotes. These results suggest longer relevant trace-back histories in
scrapie-eradication programs for animals bearing these alleles and strengthen the case for additional
challenge experiments in both homozygotes to assess potential scrapie resistance.
Published by Elsevier B.V. Open access under CC BY-NC-ND license. 1. Introduction
Scrapie is a transmissible spongiform encephalopathy (TSE) of
sheep and goats with varying symptoms appearing long after infection;
these can include weight loss, lip smacking, and ataxia (Dickinson,
1976). In sheep, strong resistance to classical scrapie is conferred by the
R171 substitution in PRNP which occurs on the “ARR” haplotype
representing codons 136, 154, and 171 (Westaway et al., 1994). This
resistance is a key component of scrapie eradication programs in manyirus; K222, at position 222 of
of the goat prion protein; IHC,
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C BY-NC-ND license. parts of the world, along with trace-backs of infected animals to
eliminate as many infectious sources as possible (Lynn et al., 2007).
In goats, there have been no resistance alleles to classical scrapie
conﬁrmed following direct oral challenge, and only two alleles (M142
and K222) shown to have extended incubation period following any
experimental challenge (Acutis et al., 2012; Goldmann et al., 1996).
However, two amino acid substitutions (S146 and K222) have been
present in ﬂocks exposed to scrapie, but absent or strongly under-
represented among scrapie cases from those ﬂocks (Acutis et al.,
2006; Bouzalas et al., 2010; Papasavva-Stylianou et al., 2007, 2011;
Vaccari et al., 2006). Further, both alleles have recently been shown to
have low cell-free prion protein conversion efﬁciency to the disease
form, PrPD (Eiden et al., 2011). Therefore we hypothesized that goats
singly heterozygous for S146 or K222 would have signiﬁcantly longer
scrapie incubation times than N146-Q222 homozygotes, and we
performed an experimental oral challenge experiment to test this
hypothesis.
2. Material and methods
To study the degree of scrapie resistance conferred by S146 and
K222, kids from three genetic backgrounds (Toggenburg, Alpine-Boer,
Table 1
Primers and conditions for allele-speciﬁc PCR genotyping.
Forward PCR primer Reverse PCR primer Annealing temp Detects allele
TCTTATACATTTTGGCAG GACAGCAATAAAGAAATGCACA 53 S146
TCTTATACATTTTGGCAA GACAGCAATAAAGAAATGCACA 53 N146
TGTGC(A/C)TCACCCA(G/T)TACAa GACAGCAATAAAGAAATGCACA 59 K222
TGTGC(A/C)TCACCCA(G/T)TACCa GACAGCAATAAAGAAATGCACA 59 Q222
a Degenerate primers designed to accommodate nearby single nucleotide polymorphisms.
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typed using allele-speciﬁc PCR (Table 1), and orally inoculated within
24 h of birth. Genotypes were later conﬁrmed by sequencing using
previous protocols (White et al., 2008). Experimental genotypes were
deﬁned as one copy of the most common PRNP haplotype and one
copy of either S146 (haplotype 1,7) or K222 (haplotype 1,10) as
described in (White et al., 2008). Control genotypes were deﬁned
as two copies of the most common haplotype (1,1) that included
N146 and Q222 (White et al., 2008). Eight of each experimental
genotype and six controls were inoculated. One control goat was
disqualiﬁed when it was subsequently determined to have an R101
allele previously reported only in Moroccan goats (Serrano et al.,
2009). Even so, the control group still included breed-matched
controls from each breed type. The oral inoculum was a frozen
homogenate including 5.0 g of placental cotyledons and 1.0 g of brain
per dose from one naturally infected goat in Tris-EDTA pH 8.0.
Scrapie diagnosis was performed by both immunohistochemical
(IHC) methods and clinical signs. Rectal mucosal biopsy (Gonzalez
et al., 2005) was taken from controls at 12 or 18 months of age and
from experimental animals at 18 and 24 months of age. Immunohis-
tochemistry for PrPD was performed using formalin ﬁxed, parafﬁn
embedded tissues labeled with monoclonal antibody F99/97.6.1
as previously described (O'Rourke et al., 2011). Clinical signs were
monitored daily by technical staff, and conﬁrmed by supervising
veterinarians. All animal procedures were approved by the Institu-
tional Animal Care and Use Committee of Washington State
University. Scrapie incubation time was analyzed using the t test
procedure in SAS 9.2 (SAS institute, Cary, NC). Both genotypic
comparisons with controls passed initial tests for equal variance, so
reported results are from equal variance two-sample t tests.3. Results
One K222 goat was euthanized at 30 months when it became lame
with swollen joints. This clinical presentation coupled with positive
serology for caprine arthritis encephalitis virus (CAEV) (Herrmann
et al., 2003) suggest lameness was a result of arthritis associated with
CAEV. PrPD was not detected in any tissues from this goat, including
obex and retropharyngeal lymph node.
All control animals became clinical with scrapie at an average
of 23.8 months post-inoculation (Table 2). PrPD was detected in theTable 2













5 Control 4 5 23.8 (20, 27) –
8 S146 0 0 – 33.6a (33, 38)
8 K222 0 0 – 44.0a (30b, 47)
a Signiﬁcantly extended incubation compared to control (Pb0.0001).
b One K222 goat was euthanized for swollen joints and lameness at 30 months but
remained scrapie negative by IHC. That animal was included in the statistical test for
extended incubation.rectal biopsy of all but one control goat by 18 months post-
inoculation. In that one control goat, PrPD was not detected in rectal
mucosal tissue despite progressing to clinical symptoms and having
positive IHC conﬁrmation of PrPD in obex.
None of the experimental animals have been positive by either
rectal biopsy or clinical signs (Table 2). Scrapie-free survival times
have been signiﬁcantly prolonged in these experimentally challenged
goats singly heterozygous in PRNP for either S146 (Pb0.0001) or
K222 (Pb0.0001). For the S146 group the average extension of
incubation has been almost 10 months. The K222 group incubation
has been extended by 20 months; this conservative estimate was
made including the scrapie-free incubation of the animal euthanized
for other reasons. Excluding this animal would result in average
scrapie-free incubation of 46 months, with average extended incu-
bation of 22 months for the K222 group.
4. Discussion
Existing data on the degree of scrapie resistance conferred by
caprine PRNP S146 and K222 rely on potentially variable exposure in
natural scrapie situations, in vitro correlates of resistance, or an
unnatural intracerebral challenge. Experimental challenge can pro-
vide the advantages of consistent inoculum and known incubation
time, and this study provided both with homogenized, goat-derived
inoculum delivered orally for what may be a more natural exposure
than other experimental routes. All the homozygous haplotype 1
control animals developed clinical disease and have been euthanized,
demonstrating the infectivity of the inoculum was consistent. None
of the animals from either the S146 or K222 heterozgyote groups
have developed clinical signs, demonstrating consistent extension of
incubation for both alleles. Speciﬁcally, the current results (Table 2)
suggest animals with one copy of S146 or K222 may not become
rectal biopsy positive or clinically affected in the same timeframe
post-exposure as common haplotype homozygous control genotypes.
Extended incubation time can create difﬁculties in correctly diagnos-
ing exposed animals. Furthermore, retrospective tracing of chains
of exposure in scrapie eradication programs (Lynn et al., 2007) may
become more difﬁcult with longer incubation times such as those
conferred by S146 or K222 because of the longer relevant exposure
histories.
Recently, scrapie cases have been reported in small numbers of
naturally-infected S146 and K222 heterozygotes (Barillet et al., 2009;
Papasavva-Stylianou et al., 2011). In each of these cases, the S146
and K222 heterozygotes were signiﬁcantly underrepresented in the
scrapie cases, which is consistent with some degree of resistance to
scrapie conferred by each allele. It is possible that differing scrapie
strains and/or additional PRNP variants may alter the degree of
resistance conferred by S146 and/or K222, but the very small number
of such positives to date limits conclusions concerning those issues at
present. However, the existence of any scrapie positives bearing these
alleles, including at least one animal with the same apparent K222
haplotype combination as this study (Papasavva-Stylianou et al.,
2011) and two animals with the same apparent S146 haplotype
combinations as this study (Barillet et al., 2009), suggests the S146
51S.N. White et al. / Gene 501 (2012) 49–51and K222 alleles may not convey as strong resistance to classical
scrapie as does R171 in sheep in the heterozygous condition
(Westaway et al., 1994), but rather may confer extended incubation
time like M142 (Goldmann et al., 1996).
In their study on M142, Goldmann et al. used many different
sources of inoculum and routes of inoculation, making direct com-
parisons with the current study challenging. However, an average
of about 13 months extended incubation was observed for M142
heterozygotes (Goldmann et al., 1996) compared to homozygotes for
the most common haplotype (I142). In the ﬁnal stages of preparing
this manuscript, a study was published demonstrating extended
incubation of K222 heterozygotes for 4.5 years following intracerebral
scrapie challenge (Acutis et al., 2012). In this oral challenge, we have
already observed a 20 month average extended survival following oral
challenge for K222 heterozygotes without clinical signs to date. This
conﬁrms the intracerebral challenge result that heterozygous K222
has the longest extended scrapie incubation time shown by experi-
mental challenge in goats to date and may convey a longer extended
scrapie incubation than heterozygous M142.
A separate question regards the scrapie resistance conveyed by
either S146 or K222 in the homozygous condition. Since the current
results demonstrate that one copy of either allele conveys some
partial scrapie resistance in goats, it is possible that homozygotes
would possess stronger resistance. Allele frequencies for both S146
and K222 are sufﬁcient to enable such an approach to achieve a high
level of such animals in a small number of generations (Vaccari et al.,
2009), should they be shown to possess strong scrapie resistance.
Additional experimental challenge data will be necessary to demon-
strate sufﬁcient resistance to pursue this approach.5. Conclusions
In conclusion, goats singly heterozygous for S146 or K222
have extended scrapie incubation times following oral scrapie chal-
lenge. The K222 heterozygote result conﬁrms a recent intracerebral
challenge, and to our knowledge this is the ﬁrst report demonstrating
extended incubation time in S146 following any experimental scrapie
challenge. These results suggest difﬁculty in correctly diagnosing
exposed S146 and K222 animals, and longer relevant trace-back
histories of exposed animals bearing these alleles. An open question is
the length of extended incubation for each genotype, and this
experiment will be ongoing to address that issue. Since the present
results also demonstrate partial scrapie resistance conferred by S146
and K222, they further suggest additional investigation into the
scrapie resistance of homozygotes for each allele.Acknowledgment
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